Anti-salusin-β antibody enhances angiogenesis after myocardial ischemia reperfusion injury

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 9, 2013, Pages 1003-1009

  Masumura, Mayumi ^a   Watanabe, Ryo ^a   Nagashima, Ayako ^a   Ogawa, Masahito ^b   Suzuki, Jun Ichi ^b   Shichiri, Masayoshi ^c   Komuro, Issei ^b   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Bioactive peptides; Myocardial ischemia; Salusin

Indexed keywords

CARDIOVASCULAR AGENT; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; SALUSIN BETA ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROBLAST; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART RATE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; ANTIBODIES; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL2; FIBROBLASTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84882646629     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.819852     Document Type: Article

References (16)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72
2. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47
3. Shimizu T, Okamoto H, Chiba S, et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res 2003;58:203-12
4. Shichiri M, Ishimaru S, Ota T, et al. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003;9:1166-725.
5. Yu F, Zhao J, Yang J, et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004;122:191-7
6. Izumiyama H, Tanaka H, Egi K, et al. Synthetic salusins as cardiac depressors in rat. Hypertension 2005;45:419-25
7. Watanabe T, Nishio K, Kanome T, et al. Impact of salusin-alpha and-beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008;117:638-488.
8. Onai Y, Suzuki J, Kakuta T, et al. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;63:51-9
9. Suzuki N, Shichiri M, Akashi T, et al. Systemic distribution of salusin expression in the rat. Hypertens Res 2007;30:1255-62
10. Sato K, Sato T, Susumu T, et al. Presence of immunoreactive salusin-beta in human plasma and urine. Regul Pept 2009;158:63-7
11. Koya T, Miyazaki T, Watanabe T, et al. Salusin-b accelerates inflammatory responses in vascular endothelial cells via NF-kB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 2012;303:H96-105
12. Suzuki J, Ogawa M, Futamatsu H, et al. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol 2006;40:688-95
13. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-54
14. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985;121:522-30
15. Cheung PY, Sawicki G, Wozniak M, et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000;101:1833-9
16. Kosuge H, Suzuki J, Kakuta T, et al. Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler Thromb Vasc Biol 2004;24:1409-15